Důsledky vysoce supresivní léčby infekce HIV
[Implications of highly suppressive treatment HIV infection]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
37827826
DOI
10.36290/vnl.2023.057
PII: 135363
- Klíčová slova
- Antiretroviral therapy, HIV, HIV reservoir, Transplantation, immune activacion, non-AIDS diseases, transplantation,
- MeSH
- antiretrovirové látky terapeutické užití MeSH
- HIV infekce * komplikace farmakoterapie MeSH
- HIV-1 * genetika MeSH
- lidé MeSH
- zánět farmakoterapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antiretrovirové látky MeSH
Treatment of HIV infection has modified the initially fatal infection into a typically chronic disease requiring lifelong treatment. However, there is no complete normalization of immune activation, signs of inflammation and prothrombotic state in treated patients. This condition is the result of many factors, but the main cause is thought to be the residual production of HIV-1 RNA and viral proteins by infected cells in cellular reservoirs. Persistence of immune activation/inflammation/prothrombotic state leads to the pathophysiology of "sterile inflammation" and so-called non-AIDS diseases, which manifest one to two decades earlier in those infected. Despite all the pitfalls and unwanted secondary manifestations of antiretroviral drugs, the treatment of HIV infection has managed to reverse the trajectory of a fatal pandemic and has made it possible to approach therapeutic modalities that were absolutely unimaginable just a few years ago. Solid organ transplantation is now a completely legitimate therapeutic method for patients living with HIV, and highly suppressive treatment even allows transplantation from an HIV-infected donor. The text below presents a brief overview of the basic pitfalls, but also of the successes, of the current highly suppressive treatment of HIV infection.
Citace poskytuje Crossref.org